Background. Many gene-expression signatures exist for describing the biological state of profiled tumors. Principal Component Analysis (PCA) can be used to summarize a gene signature into a single score. Our hypothesis is that gene signatures can be validated when applied to new datasets, using inherent properties of PCA. Results. This validation is based on four key concepts. Coherence: elements of a gene signature should be correlated beyond chance. Uniqueness: the general direction of the data being examined can drive most of the observed signal. Robustness: if a gene signature is designed to measure a single biological effect, then this signal should be sufficiently strong and distinct compared to other signals within the signature. Transferability: the derived PCA gene signature score should describe the same biology in the target dataset as it does in the training dataset. Conclusions. The proposed validation procedure ensures that PCA-based gene signatures perform as expected when applied to datasets other than those that the signatures were trained upon. Complex signatures, describing multiple independent biological components, are also easily identified.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jTprpD
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Background Liver resection of benign, primary, and metastatic tumors is challenging and places patients at risk of postoperativ...
-
Publication date: Available online 8 April 2017 Source: Cortex Author(s): Jeremy Purcell, Rajani Sebastian, Richard Leigh, Samson Jarso,...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2p4oxom via IFTTT
-
With a highly professional, friendly and compassionate staff, Coral Springs Funeral Home is the first choice for hundreds of area families e...
-
OBJECTIVE: This study was aimed to explore the underlying genes associated with lung cancer (LC) by bioinformatics analysis. DATA AND METH...
-
La Traviata The soprano Diana Damrau gave her first performance as Violetta in Verdi’s “Traviata” as it returned to the Metropolitan Opera. ...
-
Though TRAIL has been hailed as a promising drug for tumour treatment, it has been observed that many tumour cells have developed escape mec...
-
Sheffield cancer patient becomes 1000th person to have surgery using 'high-tech robot' South Yorkshire Times As well as prost...
-
Biomarkers for Hearing Dysfunction: Facts and Outlook. ORL J Otorhinolaryngol Relat Spec. 2017 Feb 24;79(1-2):93-111 Authors: Rüttige...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου